• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Video: Conducting Spirometry in Children

News
Article

Prof. Dominic Fitzgerald, a pediatric respiratory and sleep physician, reviews the basics about spirometry, and explains its use in children.

Prof. Dominic Fitzgerald, a pediatric respiratory and sleep physician, reviews the basics about spirometry, and explains its use in children.

Related Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
ACOG Publishes Revised Guidance on Maternal Immunization for COVID-19, Influenza, and RSV

ACOG Publishes Revised Guidance on Maternal Immunization for COVID-19, Influenza, and RSV

Grace Halsey
August 25th 2025
Article

ACOG CEO: “In the face of misinformation and vaccine hesitancy, a strong, evidence-based recommendation...from a trusted clinician can go a long way."

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

FDA Approves Brensocatib for Non–Cystic Fibrosis Bronchiectasis

FDA Approves Brensocatib for Non–Cystic Fibrosis Bronchiectasis

Sydney Jennings
August 14th 2025
Article

The US FDA approved brensocatib as the first treatment for non–cystic fibrosis bronchiectasis.

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

Sydney Jennings
May 20th 2022
Podcast

In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.

Solriamfetol Treatment Yields Cognitive Gains in Obstructive Sleep Apnea: Daily Dose / image credit: ©New Africa/AdobeStock

Solriamfetol Treatment Yields Cognitive Gains in Obstructive Sleep Apnea: Daily Dose

Sydney Jennings
July 29th 2025
Article

Your daily dose of the clinical news you may have missed.

Efficacy of Apnimed's Novel Oral Formulation Targeting OSA Confirmed in Second Phase 3 Trial / image credit ©Apnimed

Efficacy of Apnimed's Novel Oral Formulation Targeting OSA Confirmed in Second Phase 3 Trial

Grace Halsey
July 23rd 2025
Article

Apnimed's first-in-class anti-apneic AD109 increases upper airway muscle tone during sleep; the company plans to file an NDA with the FDA in early 2026.

© 2025 MJH Life Sciences

All rights reserved.